Ligand · 3EM
3EM · N~2~-({[7-(diethylamino)-2-oxo-2H-chromen-4-yl]methoxy}carbonyl)-N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-L-valinamide
3EM, N~2~-({[7-(diethylamino)-2-oxo-2H-chromen-4-yl]methoxy}carbonyl)-N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-L-valinamide (C43 H51 N5 O8 S, 798.0 g/mol), in the MolNFT structures on…
- Component
- 3EM
- Formula
- C43 H51 N5 O8 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
3EM in 2 structures; the first of them:
- 4U7Q · Structure of wild-type HIV protease in complex with photosensitive inhibitor PDI-6 · 3EM B101 · binds ARG8, ASP25, GLY27, ALA28, ASP29, ASP30, ILE47, GLY48 and 20 more
- 4U7Q · Structure of wild-type HIV protease in complex with photosensitive inhibitor pdi-6 · 3EM B101 · binds ARG8, ASP25, GLY27, ALA28, ASP29, ASP30, ILE47, GLY48 and 20 more
Residues it binds most
ASP 2, GLY 2, ILE 2, VAL 2, ALA 2, PRO 2, THR 2, ARG 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.